Reduction of calprotectin and phosphate during testosterone therapy in aging men: a randomized controlled trial

ConclusionCompared to the placebo group, 6  months of testosterone therapy (gel) reduced calprotectin and phosphate levels suggesting decreased inflammation and decreased cardiovascular risk.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research